LPAR6 (lysophosphatidic acid receptor 6) is the G protein-coupled receptor of the LPA family [69], and it has been known to be associated with cancer types such as hepatocellular carcinoma [70], pancreatic cancer [71] and prostate cancer [72]. Here, LPA is linked to familial pancreatic carcinoma.